These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 29202546)

  • 1. Correlation of Minichromosome Maintenance Protein 6 Expression Rate and Clinical Outcome in Patients With Hodgkin's Lymphoma.
    Khodadad K; Karimi S; Esfahani-Monfared Z; Khosravi A; Bandarchi-Chamkhaleh B
    Acta Med Iran; 2017 Sep; 55(9):550-555. PubMed ID: 29202546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of minichromosome maintenance protein 6 in classic Hodgkin's lymphoma points to a cell cycle arrest in G1 phase.
    Karimi S; Mohammadi F; Khodadad K; Emami H; Seyfollahi L
    Arch Iran Med; 2008 Sep; 11(5):532-8. PubMed ID: 18759521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
    Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis.
    Obermann EC; Went P; Zimpfer A; Tzankov A; Wild PJ; Stoehr R; Pileri SA; Dirnhofer S
    BMC Cancer; 2005 Dec; 5():162. PubMed ID: 16368013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma.
    Schrader C; Janssen D; Klapper W; Siebmann JU; Meusers P; Brittinger G; Kneba M; Tiemann M; Parwaresch R
    Br J Cancer; 2005 Oct; 93(8):939-45. PubMed ID: 16189522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer.
    Gonzalez MA; Pinder SE; Callagy G; Vowler SL; Morris LS; Bird K; Bell JA; Laskey RA; Coleman N
    J Clin Oncol; 2003 Dec; 21(23):4306-13. PubMed ID: 14645419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer.
    Meng MV; Grossfeld GD; Williams GH; Dilworth S; Stoeber K; Mulley TW; Weinberg V; Carroll PR; Tlsty TD
    Clin Cancer Res; 2001 Sep; 7(9):2712-8. PubMed ID: 11555583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent prognostic impact of tumour-infiltrating macrophages in early-stage Hodgkin's lymphoma.
    Gotti M; Nicola M; Lucioni M; Fiaccadori V; Ferretti V; Sciarra R; Costanza M; Bono E; Molo S; Maffi A; Croci GA; Varettoni M; Frigeni M; Pascutto C; Arcaini L; Bonfichi M; Paulli M; Cazzola M
    Hematol Oncol; 2017 Sep; 35(3):296-302. PubMed ID: 27060262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
    Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
    Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
    Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
    Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tryptase- and chymase-positive mast cells as possible prognostic factor in patients with Hodgkin's lymphoma].
    Rygoł B; Kyrcz-Krzemień S; Pajiak J; Konicki P; Kowai E; Gasińska T
    Pol Arch Med Wewn; 2007; 117(1-2):27-32. PubMed ID: 17642203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of topoisomerase II α and minichromosome maintenance protein 6 expression in colorectal cancer.
    Hendricks A; Gieseler F; Nazzal S; Bräsen JH; Lucius R; Sipos B; Claasen JH; Becker T; Hinz S; Burmeister G; Schafmayer C; Schrader C
    BMC Cancer; 2019 May; 19(1):429. PubMed ID: 31072339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.
    Yang J; Ramnath N; Moysich KB; Asch HL; Swede H; Alrawi SJ; Huberman J; Geradts J; Brooks JS; Tan D
    BMC Cancer; 2006 Aug; 6():203. PubMed ID: 16882345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.
    Josting A; Franklin J; May M; Koch P; Beykirch MK; Heinz J; Rudolph C; Diehl V; Engert A
    J Clin Oncol; 2002 Jan; 20(1):221-30. PubMed ID: 11773173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minichromosome Maintenance Complex is Required for Checkpoint Kinase 2 Chromatin Loading and its Phosphorylation to DNA Damage Response in SCC-4 Cells.
    Li L; Feng Y; Luo R
    Protein Pept Lett; 2017; 24(3):223-228. PubMed ID: 27964702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of expression of mini-chromosome maintenance proteins (MCMs) in patients with nasopharyngeal cancer treated with curative radiotherapy.
    Kanyilmaz G; Oltulu P; Benli Yavuz B; Aktan M
    Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S18-S25. PubMed ID: 34144903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a novel component of the human minichromosome maintenance complex.
    Sakwe AM; Nguyen T; Athanasopoulos V; Shire K; Frappier L
    Mol Cell Biol; 2007 Apr; 27(8):3044-55. PubMed ID: 17296731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma.
    Hotton J; Agopiantz M; Leroux A; Charra-Brunaud C; Marie B; Busby-Venner H; Morel O; Guéant JL; Vignaud JM; Battaglia-Hsu SF; Gauchotte G
    Virchows Arch; 2018 Apr; 472(4):623-633. PubMed ID: 29243125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.